Personal information

Other IDs

Scopus Author ID: 6603311133

Activities

Collapse all

Employment (1)

AOU Città della Salute e della Scienza di Torino: Torino, IT

(Dipartimento di Neuroscienze)
Employment
Source: Self-asserted source
Marco Vercellino

Works (49)

Long-term modifications of the peripheral immune repertoire after switching from sequestering disease-modifying treatments in multiple sclerosis

Multiple Sclerosis Journal
2024-12 | Journal article
DOI: 10.1177/13524585241284846
Contributors: Marco Vercellino; Stella Marasciulo; Emanuela Ricotti; Anna Rolando; Chiara Bosa; Paola Garelli; Virginia Gallina; Giovanna Vaula; Andrea Calvo; Paola Cavalla
Source: check_circle
Crossref

Identifying definite patterns of unmet needs in patients with multiple sclerosis using unsupervised machine learning

Neurological Sciences
2024-02-23 | Journal article
DOI: 10.1007/s10072-024-07416-9
Part of ISSN: 1590-1874
Part of ISSN: 1590-3478
Contributors: Elisabetta Maida; Gianmarco Abbadessa; Eleonora Cocco; Paola Valentino; Annalaura Lerede; Jessica Frau; Giuseppina Miele; Floriana Bile; Marco Vercellino; Francesco Patti et al.
Source: Self-asserted source
Marco Vercellino
grade
Preferred source (of 2)‎

Quality of care provided by Multiple Sclerosis Centers during Covid-19 pandemic: Results of an Italian multicenter patient-centered survey

Multiple Sclerosis and Related Disorders
2023 | Journal article
DOI: 10.1016/j.msard.2023.104870
EID:

2-s2.0-85165077175

Part of ISSN: 22110356 22110348
Contributors: Altieri, M.; Capuano, R.; Bisecco, A.; d'Ambrosio, A.; Risi, M.; Cavalla, P.; Vercellino, M.; Annovazzi, P.; Zaffaroni, M.; De Stefano, N. et al.
Source: Self-asserted source
Marco Vercellino via Scopus - Elsevier

Diagnostic value of kappa free light chain index in patients with primary progressive multiple sclerosis - a multicentre study.

Frontiers in immunology
2023-12-19 | Journal article
DOI: 10.3389/fimmu.2023.1327947
PMID: 38169789
PMC: PMC10758426
Contributors: Hegen H; Berek K; Cavalla P; Christiansen M; Emeršič A; Di Filippo M; Gaetani L; Hassler M; Leurs C; Milosavljevic D et al.
Source: Self-asserted source
Marco Vercellino
grade
Preferred source (of 2)‎

Association of MRI leptomeningeal enhancement with disability worsening in progressive multiple sclerosis: A clinical and post-mortem study.

Multiple sclerosis (Houndmills, Basingstoke, England)
2023-09-23 | Journal article
DOI: 10.1177/13524585231199031
PMID: 37740714
Contributors: Vercellino M; Costantini G; Cogoni M; Lequio L; Sciortino P; De Negri F; Marasciulo S; Valentini C; Bosa C; Garelli P et al.
Source: Self-asserted source
Marco Vercellino
grade
Preferred source (of 2)‎

May Mediterranean diet contribute to reduce risk of multiple sclerosis?

Multiple sclerosis (Houndmills, Basingstoke, England)
2023-07-29 | Journal article
DOI: 10.1177/13524585231190342
PMID: 37515480
Contributors: Paola Cavalla; Vercellino M
Source: Self-asserted source
Marco Vercellino
grade
Preferred source (of 2)‎

SARS-CoV-2 pandemic as a model to assess the relationship between intercurrent viral infections and disease activity in Multiple Sclerosis: A propensity score matched case-control study

Multiple Sclerosis and Related Disorders
2023-06 | Journal article
DOI: 10.1016/j.msard.2023.104715
Contributors: Marco Vercellino; Chiara Bosa; Anastasia Alteno; Francesco Muccio; Stella Marasciulo; Paola Garelli; Paola Cavalla
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Previous disease-modifying treatments influence T lymphocyte kinetics in people with multiple sclerosis switching to ocrelizumab.

Journal of neuroimmunology
2023-03-25 | Journal article
DOI: 10.1016/j.jneuroim.2023.578072
PMID: 36996621
Contributors: Abbadessa G; Miele G; Cavalla P; Paola VALENTINO; Marfia GA; Vercellino M; De Martino A; Simeon V; Lavorgna L; Bonavita S
Source: Self-asserted source
Marco Vercellino
grade
Preferred source (of 2)‎

Breakthrough SARS-CoV-2 infections in MS patients on disease modifying therapies

medRxiv
2022 | Other
DOI: 10.1101/2022.01.22.22269630
EID:

2-s2.0-85163920195
Contributors: Schiavetti, I.; Cordioli, C.; Stromillo, M.L.; Ferrò, M.T.; Laroni, A.; Cocco, E.; Cola, G.; Pasquali, L.; Rilla, M.T.; Signoriello, E. et al.
Source: Self-asserted source
Marco Vercellino via Scopus - Elsevier

SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study

Multiple Sclerosis Journal
2022 | Journal article
DOI: 10.1177/13524585211035318
EID:

2-s2.0-85111703879

Part of ISSN: 14770970 13524585
Contributors: Sormani, M.P.; Schiavetti, I.; Landi, D.; Carmisciano, L.; De Rossi, N.; Cordioli, C.; Moiola, L.; Radaelli, M.; Immovilli, P.; Capobianco, M. et al.
Source: Self-asserted source
Marco Vercellino via Scopus - Elsevier

Association of vitamin D serum levels and vitamin D supplementation with B cell kinetics and disease activity in Multiple Sclerosis patients treated with ocrelizumab: an Italian multi-center study.

Multiple sclerosis and related disorders
2022-11-03 | Journal article
DOI: 10.1016/j.msard.2022.104395
PMID: 36544324
Contributors: Miele G; Abbadessa G; Cavalla P; Paola VALENTINO; Marfia GA; Doriana Landi; Bosa C; Vercellino M; De Martino A; Marta Ponzano et al.
Source: Self-asserted source
Marco Vercellino
grade
Preferred source (of 2)‎

Signs and symptoms of COVID-19 in patients with multiple sclerosis.

European journal of neurology
2022-09-23 | Journal article
DOI: 10.1111/ene.15554
PMID: 36086905
PMC: PMC9538224
Contributors: Irene Schiavetti; Carmisciano L; Marta Ponzano; Cordioli C; Eleonora Cocco; Marfia GA; Matilde Inglese; Massimo Filippi; Radaelli M; Bergamaschi R et al.
Source: Self-asserted source
Marco Vercellino
grade
Preferred source (of 2)‎

Onset of multiple sclerosis in a patient on dupilumab therapy for atopic dermatitis: A case report.

Dermatologic therapy
2022-08-08 | Journal article
DOI: 10.1111/dth.15740
PMID: 35899485
PMC: PMC9788158
Contributors: Federica Gelato; Luca Mastorino; Cavalla P; Quaglino P; Cavaliere G; Vercellino M; Bosa C; Matilde Inglese; De Palma R; Ortoncelli M et al.
Source: Self-asserted source
Marco Vercellino
grade
Preferred source (of 2)‎

Fetal and post-natal growth in infants of mothers with multiple sclerosis: A case-control stud.

Multiple sclerosis and related disorders
2022-08-01 | Journal article
DOI: 10.1016/j.msard.2022.104087
PMID: 35933740
Contributors: Luca Marozio; Cavalla P; Sottemano S; Vercellino M; Federici F; Cosma S; Peila C; Cresi F; Coscia A; Capobianco M et al.
Source: Self-asserted source
Marco Vercellino
grade
Preferred source (of 2)‎

Impact of COVID-19 lockdown on progressive multiple sclerosis patients

Neurological Sciences
2022-05 | Journal article
DOI: 10.1007/s10072-022-05909-z
Contributors: Marco Vercellino; Chiara Bosa; Anastasia Alteno; Valentina Schillaci; Manuel Petracca; Stella Marasciulo; Paola Cavalla
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Dietary habits, nutritional status and risk of a first demyelinating event: an incident case-control study in a southern European cohort.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2022-02-15 | Journal article
DOI: 10.1007/s10072-022-05908-0
PMID: 35166977
Contributors: Cavalla P; Golzio P; Maietta D; Bosa C; Pasanisi MB; Alteno A; Schillaci V; Costantini G; Durelli P; Cuffini E et al.
Source: Self-asserted source
Marco Vercellino
grade
Preferred source (of 2)‎

Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis

Annals of Neurology
2021 | Journal article
DOI: 10.1002/ana.26028
EID:

2-s2.0-85100758179

Part of ISSN: 15318249 03645134
Contributors: Sormani, M.P.; De Rossi, N.; Schiavetti, I.; Carmisciano, L.; Cordioli, C.; Moiola, L.; Radaelli, M.; Immovilli, P.; Capobianco, M.; Trojano, M. et al.
Source: Self-asserted source
Marco Vercellino via Scopus - Elsevier

Paraneoplastic neuromyelitis optica spectrum disorders: a case series

Neurological Sciences
2021 | Journal article
DOI: 10.1007/s10072-021-05055-y
EID:

2-s2.0-85099933462

Part of ISSN: 15903478 15901874
Contributors: Virgilio, E.; Vecchio, D.; Vercellino, M.; Naldi, P.; Tesser, F.; Cantello, R.; Cavalla, P.; Comi, C.
Source: Self-asserted source
Marco Vercellino via Scopus - Elsevier

The effect of air pollution on COVID-19 severity in a sample of patients with multiple sclerosis.

European journal of neurology
2021-11-15 | Journal article
DOI: 10.1111/ene.15167
PMID: 34735749
PMC: PMC8652772
Contributors: Bergamaschi R; Marta Ponzano; Irene Schiavetti; Luca Carmisciano; Cordioli C; Massimo Filippi; Radaelli M; Immovilli P; Marco Capobianco; De Rossi N et al.
Source: Self-asserted source
Marco Vercellino
grade
Preferred source (of 2)‎

COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context.

Neurology(R) neuroimmunology & neuroinflammation
2021-11-09 | Journal article
DOI: 10.1212/nxi.0000000000001105
PMID: 34753829
PMC: PMC8579249
Contributors: MARIA PIA SORMANI; Irene Schiavetti; Luca Carmisciano; Cinzia Cordioli; Massimo Filippi; Radaelli M; paolo immovilli; Capobianco M; De Rossi N; Brichetto G et al.
Source: Self-asserted source
Marco Vercellino

Case Report: Covid-19 in Multiple Sclerosis Patients Treated With Ocrelizumab: A Case Series.

Frontiers in neurology
2021-10-20 | Journal article
DOI: 10.3389/fneur.2021.691616
PMID: 34744958
PMC: PMC8563620
Contributors: De Mercanti SF; Vercellino M; Bosa C; Alteno A; Schillaci V; Marinella CLERICO; Cavalla P
Source: Self-asserted source
Marco Vercellino
grade
Preferred source (of 2)‎

CD19 Cell Count at Baseline Predicts B Cell Repopulation at 6 and 12 Months in Multiple Sclerosis Patients Treated with Ocrelizumab.

International journal of environmental research and public health
2021-08-02 | Journal article
DOI: 10.3390/ijerph18158163
PMID: 34360456
PMC: PMC8346113
Contributors: Abbadessa G; Miele G; Paola Cavalla; Paola VALENTINO; Marfia GA; Signoriello E; Doriana Landi; Chiara Bosa; Vercellino M; De Martino A et al.
Source: Self-asserted source
Marco Vercellino
grade
Preferred source (of 2)‎

Acute and chronic synaptic pathology in multiple sclerosis gray matter.

Multiple sclerosis (Houndmills, Basingstoke, England)
2021-06-14 | Journal article
DOI: 10.1177/13524585211022174
PMID: 34124960
Contributors: Vercellino M; Marasciulo S; Grifoni S; Vallino-Costassa E; Bosa C; Pasanisi MB; Crociara P; Casalone C; Chiò A; Giordana MT et al.
Source: Self-asserted source
Marco Vercellino
grade
Preferred source (of 2)‎

Assessing balance in non-disabled subjects with multiple sclerosis: Validation of the Fullerton Advanced Balance Scale

Multiple Sclerosis and Related Disorders
2020 | Journal article
DOI: 10.1016/j.msard.2020.102085
EID:

2-s2.0-85083886167

Part of ISSN: 22110356 22110348
Contributors: Mestanza Mattos, F.G.; Gervasoni, E.; Anastasi, D.; Giovanni, R.D.; Tacchino, A.; Brichetto, G.; Carpinella, I.; Confalonieri, P.; Vercellino, M.; Solaro, C. et al.
Source: Self-asserted source
Marco Vercellino via Scopus - Elsevier

Inhibition of human neutrophil functions in vitro by multiple sclerosis disease-modifying therapies

Journal of Clinical Medicine
2020 | Journal article
DOI: 10.3390/jcm9113542
EID:

2-s2.0-85105245481

Part of ISSN: 20770383
Contributors: Scutera, S.; Musso, T.; Cavalla, P.; Piersigilli, G.; Sparti, R.; Comini, S.; Vercellino, M.; Cuffini, A.M.; Banche, G.; Allizond, V.
Source: Self-asserted source
Marco Vercellino via Scopus - Elsevier

Kappa free light chains index in the differential diagnosis of Multiple Sclerosis from Neuromyelitis optica spectrum disorders and other immune-mediated central nervous system disorders

Journal of Neuroimmunology
2020 | Journal article
DOI: 10.1016/j.jneuroim.2019.577122
EID:

2-s2.0-85076128087

Part of ISSN: 18728421 01655728
Contributors: Cavalla, P.; Caropreso, P.; Limoncelli, S.; Bosa, C.; Pasanisi, M.B.; Schillaci, V.; Alteno, A.; Costantini, G.; Giordana, M.T.; Mengozzi, G. et al.
Source: Self-asserted source
Marco Vercellino via Scopus - Elsevier

Overexpression of sphingosine-1-phosphate receptors on reactive astrocytes drives neuropathology of multiple sclerosis rebound after fingolimod discontinuation

Multiple Sclerosis Journal
2018 | Journal article
DOI: 10.1177/1352458518763095
EID:

2-s2.0-85049019585

Part of ISSN: 14770970 13524585
Contributors: Giordana, M.T.; Cavalla, P.; Uccelli, A.; Laroni, A.; Bandini, F.; Vercellino, M.; Mancardi, G.
Source: Self-asserted source
Marco Vercellino via Scopus - Elsevier

Inflammatory responses in Multiple Sclerosis normal-appearing white matter and in non-immune mediated neurological conditions with wallerian axonal degeneration: A comparative study

Journal of Neuroimmunology
2017 | Journal article
DOI: 10.1016/j.jneuroim.2017.09.004
EID:

2-s2.0-85029445365

Part of ISSN: 18728421 01655728
Contributors: Vercellino, M.; Trebini, C.; Capello, E.; Mancardi, G.L.; Giordana, M.T.; Cavalla, P.
Source: Self-asserted source
Marco Vercellino via Scopus - Elsevier

Progranulin genetic polymorphisms influence progression of disability and relapse recovery in multiple sclerosis

Multiple Sclerosis
2016 | Journal article
DOI: 10.1177/1352458515610646
EID:

2-s2.0-84978127615

Part of ISSN: 14770970 13524585
Contributors: Vercellino, M.; Fenoglio, C.; Galimberti, D.; Mattioda, A.; Chiavazza, C.; Binello, E.; Pinessi, L.; Giobbe, D.; Scarpini, E.; Cavalla, P.
Source: Self-asserted source
Marco Vercellino via Scopus - Elsevier

Parity is associated with a longer time to reach irreversible disability milestones in women with multiple sclerosis

Multiple Sclerosis
2015 | Journal article
DOI: 10.1177/1352458514561907
EID:

2-s2.0-84940926166

Part of ISSN: 14770970 13524585
Contributors: Masera, S.; Cavalla, P.; Prosperini, L.; Mattioda, A.; Mancinelli, C.; Superti, G.; Chiavazza, C.; Vercellino, M.; Pinessi, L.; Pozzilli, C.
Source: Self-asserted source
Marco Vercellino via Scopus - Elsevier

A cross-sectional, multicentre study of the therapeutic management of multiple sclerosis relapses in Italy

Neurological Sciences
2013 | Journal article
DOI: 10.1007/s10072-012-0981-5
EID:

2-s2.0-84879693371

Part of ISSN: 15901874 15903478
Contributors: Annovazzi, P.; Tomassini, V.; Bodini, B.; Boffa, L.; Calabrese, M.; Cocco, E.; Cordioli, C.; De Luca, G.; Frisullo, G.; Gallo, A. et al.
Source: Self-asserted source
Marco Vercellino via Scopus - Elsevier

Expression and genetic analysis of microRNAs involved in multiple sclerosis

International Journal of Molecular Sciences
2013 | Journal article
DOI: 10.3390/ijms14034375
EID:

2-s2.0-84875061922

Part of ISSN: 16616596 14220067
Contributors: Ridolfi, E.; Fenoglio, C.; Cantoni, C.; Calvi, A.; De Riz, M.; Pietroboni, A.; Villa, C.; Serpente, M.; Bonsi, R.; Vercellino, M. et al.
Source: Self-asserted source
Marco Vercellino via Scopus - Elsevier

Progranulin expression in brain tissue and cerebrospinal fluid levels in multiple sclerosis

Multiple Sclerosis Journal
2011 | Journal article
DOI: 10.1177/1352458511406164
EID:

2-s2.0-80053226483

Part of ISSN: 14770970 13524585
Contributors: Vercellino, M.; Grifoni, S.; Romagnolo, A.; Masera, S.; Mattioda, A.; Trebini, C.; Chiavazza, C.; Caligiana, L.; Capello, E.; Mancardi, G.L. et al.
Source: Self-asserted source
Marco Vercellino via Scopus - Elsevier

HLA-class i markers and multiple sclerosis susceptibility in the Italian population

Genes and Immunity
2010 | Journal article
DOI: 10.1038/gene.2009.101
EID:

2-s2.0-77649342927

Part of ISSN: 14664879 14765470
Contributors: Bergamaschi, L.; Leone, M.A.; Fasano, M.E.; Guerini, F.R.; Ferrante, D.; Bolognesi, E.; Barizzone, N.; Corrado, L.; Naldi, P.; Agliardi, C. et al.
Source: Self-asserted source
Marco Vercellino via Scopus - Elsevier

Neuropathology of olfactory ensheathing cell transplantation into the brain of two amyotrophic lateral sclerosis (ALS) patients

Brain Pathology
2010 | Journal article
DOI: 10.1111/j.1750-3639.2009.00353.x
EID:

2-s2.0-77953222299

Part of ISSN: 17503639 10156305
Contributors: Giordana, M.T.; Grifoni, S.; Votta, B.; Magistrello, M.; Vercellino, M.; Pellerino, A.; Navone, R.; Valentini, C.; Calvo, A.; Chiò, A.
Source: Self-asserted source
Marco Vercellino via Scopus - Elsevier

Progranulin gene variability increases the risk for primary progressive multiple sclerosis in males

Genes and Immunity
2010 | Journal article
DOI: 10.1038/gene.2010.18
EID:

2-s2.0-77956342941

Part of ISSN: 14664879 14765470
Contributors: Fenoglio, C.; Scalabrini, D.; Esposito, F.; Comi, C.; Cavalla, P.; De Riz, M.; Martinelli, V.; Piccio, L.M.; Venturelli, E.; Fumagalli, G. et al.
Source: Self-asserted source
Marco Vercellino via Scopus - Elsevier

TDP-43 redistribution is an early event in sporadic amyotrophic lateral sclerosis

Brain Pathology
2010 | Journal article
DOI: 10.1111/j.1750-3639.2009.00284.x
EID:

2-s2.0-75949105684

Part of ISSN: 10156305 17503639
Contributors: Giordana, M.T.; Piccinini, M.; Grifoni, S.; De Marco, G.; Vercellino, M.; Magistrello, M.; Pellerino, A.; Buccinnà, B.; Lupino, E.; Rinaudo, M.T.
Source: Self-asserted source
Marco Vercellino via Scopus - Elsevier

Demyelination, inflammation, and neurodegeneration in multiple sclerosis deep gray matter

Journal of Neuropathology and Experimental Neurology
2009 | Journal article
DOI: 10.1097/NEN.0b013e3181a19a5a
EID:

2-s2.0-70149124713

Part of ISSN: 00223069
Contributors: Vercellino, M.; Masera, S.; Lorenzatti, M.; Condello, C.; Merola, A.; Mattioda, A.; Tribolo, A.; Capello, E.; Mancardi, G.L.; Mutani, R. et al.
Source: Self-asserted source
Marco Vercellino via Scopus - Elsevier

Multiple sclerosis relapses: A multivariable analysis of residual disability determinants

Acta Neurologica Scandinavica
2009 | Journal article
DOI: 10.1111/j.1600-0404.2008.01076.x
EID:

2-s2.0-58449114829

Part of ISSN: 00016314 16000404
Contributors: Vercellino, M.; Romagnolo, A.; Mattioda, A.; Masera, S.; Piacentino, C.; Merola, A.; Chiò, A.; Mutani, R.; Cavalla, P.
Source: Self-asserted source
Marco Vercellino via Scopus - Elsevier

Involvement of the choroid plexus in multiple sclerosis autoimmune inflammation: A neuropathological study

Journal of Neuroimmunology
2008 | Journal article
DOI: 10.1016/j.jneuroim.2008.04.035
EID:

2-s2.0-47549118268

Part of ISSN: 01655728
Contributors: Vercellino, M.; Votta, B.; Condello, C.; Piacentino, C.; Romagnolo, A.; Merola, A.; Capello, E.; Mancardi, G.L.; Mutani, R.; Giordana, M.T. et al.
Source: Self-asserted source
Marco Vercellino via Scopus - Elsevier

Altered glutamate reuptake in relapsing-remitting and secondary progressive multiple sclerosis cortex: Correlation with microglia infiltration, demyelination, and neuronal and synaptic damage

Journal of Neuropathology and Experimental Neurology
2007 | Journal article
DOI: 10.1097/nen.0b013e31812571b0
EID:

2-s2.0-34548297818

Part of ISSN: 00223069
Contributors: Vercellino, M.; Merola, A.; Piacentino, C.; Votta, B.; Capello, E.; Mancardi, G.L.; Mutani, R.; Giordana, M.T.; Cavalla, P.
Source: Self-asserted source
Marco Vercellino via Scopus - Elsevier

Fertility in patients with multiple sclerosis: Current knowledge and future perspectives

Neurological Sciences
2006 | Journal article
DOI: 10.1007/s10072-006-0676-x
EID:

2-s2.0-33749047289

Part of ISSN: 15901874
Contributors: Cavalla, P.; Rovei, V.; Masera, S.; Vercellino, M.; Massobrio, M.; Mutani, R.; Revelli, A.
Source: Self-asserted source
Marco Vercellino via Scopus - Elsevier

Grey matter pathology in multiple sclerosis

Journal of Neuropathology and Experimental Neurology
2005 | Journal article
DOI: 10.1097/01.jnen.0000190067.20935.42
EID:

2-s2.0-33644793370

Part of ISSN: 00223069
Contributors: Vercellino, M.; Plano, F.; Votta, B.; Mutani, R.; Giordana, M.T.; Cavalla, P.
Source: Self-asserted source
Marco Vercellino via Scopus - Elsevier

Risk of cancer in patients with Guillain-Barré syndrome (GBS): A population-based study

Journal of Neurology
2004 | Journal article
DOI: 10.1007/s00415-004-0317-3
EID:

2-s2.0-12144290998

Part of ISSN: 03405354
Contributors: Vigliani, M.-C.; Magistrello, M.; Polo, P.; Mutani, R.; Chiò, A.; Calvo, A.; Di Vito, N.; Vercellino, M.; Bertolotto, A.; Bottacchi, E. et al.
Source: Self-asserted source
Marco Vercellino via Scopus - Elsevier

Amyotrophic lateral sclerosis associated with pregnancy: Report of four new cases and review of the literature

Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders
2003 | Journal article
DOI: 10.1080/14660820310006724
EID:

2-s2.0-0038137136

Part of ISSN: 14660822
Contributors: Chiò, A.; Calvo, A.; Di Vito, N.; Vercellino, M.; Chiglione, P.; Terreni, A.A.; Mutani, R.; Mora, G.
Source: Self-asserted source
Marco Vercellino via Scopus - Elsevier

Cesare Lombroso, cortical dysplasia, and epilepsy: Keen findings and odd theories

Neurology
2003 | Journal article
DOI: 10.1212/01.WNL.0000094383.65150.07
EID:

2-s2.0-0345305696

Part of ISSN: 00283878
Contributors: Chiò, A.; Spreafico, R.; Avanzini, G.; Ghiglione, P.; Vercellino, M.; Mutani, R.
Source: Self-asserted source
Marco Vercellino via Scopus - Elsevier

Guillain-Barré syndrome: A prospective, population-based incidence and outcome survey

Neurology
2003 | Journal article
DOI: 10.1212/01.WNL.0000055091.96905.D0
EID:

2-s2.0-0037426395

Part of ISSN: 00283878
Contributors: Chiò, A.; Cocito, D.; Leone, M.; Giordana, M.T.; Mora, G.; Mutani, R.; Calvo, A.; Di Vito, N.; Vercellino, M.; Bertolotto, A. et al.
Source: Self-asserted source
Marco Vercellino via Scopus - Elsevier

Validity of hospital morbidity records for amyotrophic lateral sclerosis: A population-based study

Journal of Clinical Epidemiology
2002 | Journal article
DOI: 10.1016/S0895-4356(02)00409-2
EID:

2-s2.0-0036344910

Part of ISSN: 08954356
Contributors: Chiò, A.; Ciccone, G.; Calvo, A.; Vercellino, M.; Di Vito, N.; Ghiglione, P.; Mutani, R.
Source: Self-asserted source
Marco Vercellino via Scopus - Elsevier

Conjugal amyotrophic lateral sclerosis: Suggestion for the implication of environmental factors

Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders
2001 | Journal article
DOI: 10.1080/146608201753275526
EID:

2-s2.0-0035665049

Part of ISSN: 14660822
Contributors: Chiò, A.; Hernandez, E.H.; Discalzi, G.; Ghiglione, P.; Di Vito, N.; Calvo, A.; Vercellino, M.; Plano, F.; Mutani, R.
Source: Self-asserted source
Marco Vercellino via Scopus - Elsevier
How many people are using ORCID?